SXPCX
Price
$47.73
Change
-$1.46 (-2.97%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

SXPCX vs VFINX

Header iconSXPCX vs VFINX Comparison
Open Charts SXPCX vs VFINXBanner chart's image
DWS S&P 500 Index C
Price$47.73
Change-$1.46 (-2.97%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
SXPCX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SXPCX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SXPCX is a StrongBuy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. SXPCX (1.43B). VFINX pays higher dividends than SXPCX: VFINX (1.24) vs SXPCX (0.20). SXPCX was incepted earlier than VFINX: SXPCX (20 years) vs VFINX (48 years). SXPCX (2.00) and VFINX (2.00) have comparable annual turnover. VFINX has a lower initial minimum investment than SXPCX: VFINX (0) vs SXPCX (1000). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. SXPCX (22.32). VFINX return over 5 years is better than : 88.65 vs. SXPCX (49.88).
SXPCXVFINXSXPCX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years48 years-
Gain YTD21.56627.27579%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.43B1.37T0%
Annual Yield % from dividends0.201.2416%
Returns for 1 year22.3227.6381%
Returns for 3 years14.4030.9946%
Returns for 5 years49.8888.6556%
Returns for 10 years96.59193.6250%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc